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characterized by arterial aneurysms at an early age (mean age at death, 26.0
years). There was also a high incidence of pregnancy-related complications
in 6 of 12 women. Compared with patients with Loeys-Dietz syndrome type
2, those with Loeys-Dietz syndrome type 1 underwent cardiovascular sur-
gery at an earlier age (mean age, 16.9 years vs 26.9 years) and died an earlier
age (22.6 vs 31.8 years). In the 59 surgeries in the cohort of patients studied,
there was only one death during the procedure, distinguishing Loeys-Dietz
syndrome from vascular Ehlers-Danlos syndrome.
Comment:Mutations of genes in coding for TGF- receptors 1 and 2
are associated with a continuum of clinical features, includingmutations that
result inMarfan syndrome, those associated with the Loeys-Dietz syndrome,
and those associated with vascular Ehlers-Danlos syndrome. Given the
different phenotypic characteristics of patients with TGF- receptor
mutations and the potential for pharmacologic manipulation of TGF-
receptors, a study such as this that characterizes phenotype with genotype
is crucial to more precisely target therapy in patients with genetically
based disorders.
Identification Of Patients At Low Risk For Recurrent Venous Throm-
boembolism By Measuring Thrombin Generation
Hron G, Kollars N, Binder BR, et al. JAMA, 2006;296:397-402.
Conclusion: Patients at low risk for recurrent venous thromboembo-
lism (VTE) can be identified by measurement of thrombin generation.
Summary: Patients with VTE are often investigated for thrombophilic
risk factors. The large number of potential thrombophilic risk factors makes
this complex and expensive. The authors sought to determine whether the
risk of recurrent VTE could be assessed by a global coagulation assay that
measures thrombin generation.
This was a prospective cohort study of 914 patients. All patients had a
spontaneous VTE and were followed for an average of 47 months after
discontinuation of oral anticoagulant therapy. The study period was from
July 1992 to July 2005. A commercially available assay was used to measure
thrombin generation. Excluded patients included those with secondary
VTE, those with recurrent VTE, or those with a known thrombophilic risk
factor such as antithrombin, protein C or protein S deficiencies, the presence
of lupus anticoagulant, or cancer or pregnancy. The primary outcome
measure was an objectively documented episode of recurrent VTE.
VTE recurred in 100 patients (11%). There was lower thrombin
generation in the patients without recurrent VTE compared with those with
recurrent VTE (349.2 108 nN vs 415 110.5 nN, P .001). In patients
with thrombin generation values between 400 nN and 300 nN, the
relative risk of recurrence compared to patients with thrombin genera-
tions 400 nN was 0.42 (95% confidence interval [CI], 0.26 to 0.67, P
 .001). In patients with measured thrombin generations 300 nN
relative risk was 0.37 (95% CI, 0.21 to 0.66, P  .001). For 4 years, the
probability of VTE recurrence in patients with thrombin generation
400 nN was 6.5% (95% CI, 4.0% to 8.9%). In those patients with
thrombin generation values400, the probability of VTE recurrence was
20.0% (95% CI, 14.9% to 25.1%, P  .001). Patients with thrombin
generation400 nN had a 60% lower recurrence of VTE than those with
greater values of thrombin generation (relative risk, 0.40; 95% CI, 0.27
to 0.60; P  .001.
Comment:There are data to suggest that patients with idiopathic VTE
benefit from longer periods of anticoagulation than those with VTE and a
recognizable risk factor such as surgery or trauma. Given the implications of
long-term anticoagulant therapy, it is desirable to identify which patients
with idiopathic VTE are particularly prone to recurrence. If this study can be
confirmed by others, measurement of thrombin generation may prove to be
a relatively simple method of stratifying patients for their length of antico-
agulation after a first time episode of idiopathic VTE.
An Audit Demonstrating A Reduction In MRSA Infection In A Spe-
cialised Vascular Unit Resulting From A Change In Infection Control
Protocol
Thompson M. Eur J Vasc Endovasc Surg 2006;31:609-15.
Conclusion: Changes in infection control policy can markedly reduce
MRSA infection in a vascular surgery unit.
Summary:Methicillin-resistant Staphylococcus aureus (MRSA) is most
often a hospital-acquired infection. Rates of infection are continuing to rise
worldwide. It has become the singlemost common organism associated with
complex wound and graft infections after vascular surgery. (Eur J Vasc
Endovasc Surg, 2001;21:289-94). The author sought to evaluate if changes
in infection control policies could reduce MRSA infection in their vascular
surgical unit.
In the author’s vascular surgical ward in 2003, 18% of admissions were
colonized by MRSA. There was a 10.6% MRSA infection rate at that time.
Practice at that point was to segregate patients with proven MRSA from the
rest of the patients on the ward. The author performed a prospective audit
using regression analysis to identify factors that may stratify patients into low
and high risk for MRSA colonization. An isolation policy was then intro-
duced to segregate patients according to their risk of MRSA acquisition. All
patients undergoing prosthetic vascular reconstruction were isolated. In
addition, antibiotic policy was also altered. The MRSA status of 777 inpa-
tients was evaluated and data were prospectively recorded during three time
spans. Period 1 was November 2002 through April 2003, the period before
the change in isolation and antibiotic policy. Period 2 was August 2003
through December 2003, and period 3 was October 2004 through January
2005, after the changes in infection control policy.
In period 1, hospital acquiredMRSA colonization was 10.6%. This was
reduced to 1.1% and 1.4% in periods 2 and 3, respectively (P .001).MRSA
infection rates also fell from 10.6% in period 1 to 2.9% and 0.9% over the
same time frame (P  .01). Changes in MRSA infection rates were most
pronounced in patients undergoing aneurysm repair (MRSA infection,
30.1% in period 1 vs 3.9% and 2.9% in periods 2 and 3) and lower limb
revascularization (31% vs 0% vs 4.2%). Regression analysis indicated that the
isolation system was a significant factor in reducing MRSA infection and
colonization rates (P  .001).
Comment: This study was performed in a hospital where vascular
surgical patients were housed in multipatient rooms; therefore, it may not
apply to many US hospitals where many patients have individual rooms.
Nevertheless, the idea of identifying patients at risk for MRSA infection and
instituting infection control policies based on risk rather than on actual
infection is interesting and indicates a proactive approach to this difficult
problem. It is certainly possible that even in hospitals with individual patient
rooms, a policy of increased contact precautions in patients at risk of MRSA
infection may prove worthwhile.
Mortality In Cardiac And Vascular Outcomes In Extremely Obese
Women
McTigue K, Larson JC, Valoski A, et al. JAMA, 2006;296:79-86.
Conclusion: Weight related health risk varies with degree of excess
weight and is independent of race, smoking status, education, United States
region, and physical activity level.
Summary: Obesity is defined as a body mass index (BMI) of 30.
There are three categories of obesity: obesity 1 (BMI, 30 to 34.9), obesity 2
(BMI, 35 to 39.9), and extreme obesity (BMI,40). The latter category
of extreme obesity is increasing rapidly in the United States, particularly
in women. The prevalence of women with a BMI of50 has increased by
five times over the period of 1986 to 2000 (Arch Intern Med 2003;163:
2146-8).
The authors sought to examine the health risks of extreme obesity and
to determine how cardiovascular and mortality risks differ across clinical
weight categories in women. Patients were recruited from 40 US centers
involved in the Women’s Health Initiative Observational Study. From this
study, 90,185 women were examined for incident mortality and cardiovas-
cular outcomes and stratified according to weight status. Patients were
followed up for an average of 7.0 years, fromOctober 1, 1993 to August 31,
2004. The main outcome measures included mortality, incidents of coro-
nary heart disease, diabetes, and hypertension, stratified according to obesity
class with a focus on extreme obesity.
The prevalence of extreme obesity varied with race and ethnicity. The
incidence was 1% in Asian and Pacific Islanders and increased to 10% among
black women. For patients with a body mass index within the normal range,
the all-cause mortality rate per 10,000 person-years was 68.39 (95% confi-
dence interval [CI], 65.26 to 71.68). For patients considered overweight
but not obese, all-cause mortality rate was 71.16 (95% CI, 67.68 to 74.82).
The all-cause mortality rates were 84.47 (95% CI, 78.90 to 90.42) for
obesity category 1, 102.85 (95% CI, 92.9 to 113.86) for obesity category 2,
and 116.85 (95% CI, 103.36 to 132.11) for extreme obesity.
Adjustments for age, smoking, educational achievement, US region,
and physical activity indicated all-cause mortality, coronary heart disease
mortality, and coronary heart disease incidents were not affected by race or
ethnicity. There were positive trends in all-cause mortality and coronary
heart disease incidents with increasing weight category among both white
and black participants in the study. Most of the obesity-related mortality and
coronary heart disease risks were mediated by hyperlipidemia, hypertension,
and diabetes. Weight-related all-cause mortality was modified by age in
white women, with obesity conferring less risk among older white women.
Comment: In my hospital, it seems that there is a 300-pound person in
every elevator. The obesity epidemic is well established. To those of us who
take care of patients, it is not surprising that mortality risks can be stratified
by level of obesity. Overweight—but not obese—women may be initially
comforted by the fact that overweight was not associated with increased
mortality in this study. However, overweight was associated with increased
risk of coronary heart disease incidents, and there certainly is considerable
mortality and morbidity associated with coronary heart disease. It may be
that the 7-year period of observation in this study is insufficient to detect the
long-term health effects of just being overweight but not obese.
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